CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,674 | +642.4% | 147 | +818.8% | 0.00% | – |
Q2 2023 | $899 | -70.0% | 16 | -60.0% | 0.00% | – |
Q3 2022 | $3,000 | +50.0% | 40 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 40 | +33.3% | 0.00% | – |
Q1 2022 | $2,000 | -90.9% | 30 | -89.8% | 0.00% | -100.0% |
Q4 2021 | $22,000 | -42.1% | 294 | -13.5% | 0.00% | -66.7% |
Q3 2021 | $38,000 | +442.9% | 340 | +639.1% | 0.00% | +200.0% |
Q2 2021 | $7,000 | +16.7% | 46 | 0.0% | 0.00% | – |
Q1 2021 | $6,000 | -25.0% | 46 | -11.5% | 0.00% | -100.0% |
Q4 2020 | $8,000 | – | 52 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |